ANDROGENETIC ALOPECIA
Clinical trials for ANDROGENETIC ALOPECIA explained in plain language.
Never miss a new study
Get alerted when new ANDROGENETIC ALOPECIA trials appear
Sign up with your email to follow new studies for ANDROGENETIC ALOPECIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
One-shot nanofat injection may beat daily hair loss treatments
Disease control Not yet recruitingThis study compares a single injection of nanofat (processed fat) against PRP injections or daily topical minoxidil for treating male and female pattern hair loss. Sixty adults aged 18-50 with confirmed androgenetic alopecia will be enrolled. The goal is to see if nanofat offers …
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE4 • Sponsor: Assiut University • Aim: Disease control
Last updated May 26, 2026 12:08 UTC
-
Can lasers and stem cell juice regrow hair? new trial aims to find out
Disease control Not yet recruitingThis study tests if combining a fractional laser with a topical exosome solution (derived from stem cells) can improve hair regrowth in men with male pattern baldness. Thirty men aged 18-50 with moderate hair loss will receive three laser treatments, with half the scalp also gett…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
New hair loss pill enters final testing phase
Disease control Not yet recruitingThis study tests an oral medication (N1087, a form of minoxidil) against a placebo in 372 men aged 18 to 60 with moderate male pattern baldness. Participants take a pill once daily for 24 weeks, starting with a low dose that increases over the first 8 weeks. The goal is to see if…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated May 26, 2026 12:04 UTC
-
Amniotic fluid injection could be new hope for baldness
Disease control Not yet recruitingThis study tests whether an experimental product called XVIE, made from processed human amniotic fluid, is safe and may help regrow hair in 30 adults with common pattern baldness. Participants receive either XVIE or a placebo injected into the scalp twice, 90 days apart, and are …
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE1, PHASE2 • Sponsor: Restore Biologics Holdings, Inc. dba Xtressé • Aim: Disease control
Last updated May 18, 2026 12:12 UTC
-
New hair loss drug combo enters human trials
Disease control Not yet recruitingThis early-stage trial tests a topical gel (AD-303A) and an oral pill (AD-3031) in 30 men aged 19–55 with male pattern baldness. The goal is to see how the drug moves through the body and if it is safe. The study is not yet recruiting and will help choose the right dose for futur…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE1, PHASE2 • Sponsor: Moogene Medi Co., Ltd • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
AI set to revolutionize hair loss diagnosis
Diagnosis Not yet recruitingThis study aims to train and test artificial intelligence (AI) models to diagnose male and female pattern hair loss (androgenetic alopecia) and assess its severity. Researchers will use images from a handheld dermoscope along with patient age and sex to teach the AI. The goal is …
Matched conditions: ANDROGENETIC ALOPECIA
Sponsor: Cairo University • Aim: Diagnosis
Last updated May 26, 2026 12:12 UTC